Mental Health Channel
Topics & Medications
Related Channels

Generic Dexmethylphenidate Extended-Release

It is now possible to buy dexmethylphenidate extended-release (Focalin XR) in generic form. The generic versions come in three strengths and are made by various manufacturers. All of these products have been assigned an "AB" rating by the FDA. This means they are considered equivalent to the brand-name version; however, they are allowed to contain different inactive ingredients.

Generic Dexmethylphenidate Extended-Release: An Overview

Dexmethylphenidate extended-release (Focalin XR®) is a prescription medication that has been licensed to treat attention deficit hyperactivity disorder (ADHD). Although dexmethylphenidate extended-release is a stimulant, it has effects that are the opposite of what would be expected of a stimulant. While stimulants like caffeine can cause hyperactivity, dexmethylphenidate extended-release has a calming effect.
Brand-name Focalin XR is manufactured by Novartis Pharmaceuticals. Some strengths of this medication are available in generic form.

Availability of Generic Dexmethylphenidate Extended-Release

Generic versions of this medication are available in the following strengths:
  • Dexmethylphenidate 15 mg extended-release capsules
  • Dexmethylphenidate 30 mg extended-release capsules
  • Dexmethylphenidate 40 mg extended-release capsules.
It is made by manufacturers such as:
  • Mylan Pharmaceuticals, Inc.
  • Par Pharmaceutical Companies, Inc.
  • Teva Pharmaceuticals USA, Inc.
It's not clear when exactly you can expect the other strengths of dexmethylphenidate extended-release to "go generic." There have already been several lawsuits between drug manufacturers concerning patent expirations.

Is Generic Dexmethylphenidate Extended-Release as Good as Focalin XR?

All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns a rating to each one.
An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic versions of dexmethylphenidate extended-release currently available have an "AB" rating, meaning they should be equivalent to the brand-name product.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities. 
Recognizing Symptoms of ADHD

Dexmethylphenidate Extended-Release Info

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.